Skip to main content
AAN.com
Brief Communications
February 11, 2003
Letter to the Editor

Evidence of cardiac ischemia during seizures in drug refractory epilepsy patients

February 11, 2003 issue
60 (3) 492-495

Abstract

The authors investigated whether patients with drug refractory epilepsy have cardiovascular abnormalities that might be related to a high frequency of sudden death. Twenty-three subjects underwent comprehensive cardiovascular evaluations before and during video-EEG monitoring. ST-segment depression occurred in 40% and was associated with a higher maximum heart rate during seizures. These data suggest that cardiac ischemia may occur in these patients.

Get full access to this article

View all available purchase options and get full access to this article.

Supplementary Material

File (et1.doc)
File (et2.doc)

References

1.
Pedley TA, Hauser WA. Sudden death in epilepsy: a wake-up call for management. Lancet . 2002; 359: 1790–1791.
2.
Nillson L, Farahmand BY, Persson PG, Thilbin I, Thompson T. Risk factors for sudden unexpected death in epilepsy: a case control study. Lancet . 1999; 253: 888–893.
3.
Walczak TS, Leppik IE, D’Amelio M, et al. Incidence and risk factors in sudden unexpected death in epilepsy—A prospective cohort study. Neurology . 2001; 56: 519–525.
4.
Nei M, Ho RT, Sperling MR. EKG abnormalities during partial seizures in refractory epilepsy. Epilepsia . 2000; 41: 542–548.
5.
Tigaran S, Rasmussen V, Dam M, Pedersen S, Høgenhaven H, Friberg B. ECG changes in epilepsy patients. Acta Neurol Scand . 1997; 96: 72–75.
6.
Hennessy MJ, Tighe MG, Binnie CD, Nashef L. Sudden withdrawal of carbamazepine increases cardiac sympathetic activity in sleep. Neurology . 2001; 57: 1650–1654.
7.
Panting JR, Gatehouse PD, Yang GZ, et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med . 2002; 346: 1948–1953.
8.
Watanabe J, Thamilarasan M, Blackstone EH, Thomas JD, Lauer MS. Heart rate recovery immediately after treadmill exercise and left ventricular systolic dysfunction as predictors of mortality: the case of stress echocardiography. Circulation . 2001; 104: 1911–1916.
9.
Manca C, Dei Cas L, Bernardini B, et al. Comparative evaluation of exercise ST Response in healthy males and females. A computer study. Cardiology . 1984; 71: 341–347.
10.
Duncan HW, Barnard RJ, Grimditch GK, Vinten-Johansen J, Buckberg GD. Cardiovascular response to sudden strenuous exercise. Basic Res Cardiol . 1987; 82: 226–232.
Letters to the Editor
20 August 2003
Evidence of cardiac ischemia during seizures in drug refractory epilepsy patients
Claudia Stollberger, Krankenanstalt Rudolfstiftung
Joseph Finsterer

Myocardial ischemia and arrhythmia are possible pathomechanisms for sudden unexplained death in epilepsy patients(SUDEP). To assess cardiovascular abnormalities in 23 patients with refractory epilepsy, Tigaran et al. performed noninvasive investigations (12-lead resting ECG, Holter-monitoring, echocardiography, ergometric exercise test, myocardial scintigraphy), and, if abnormalities were found, coronary angiography[1]. During video-EEG monitoring 125 seizures occurred. Holter-monitoring found that 40% (9/22) of patients had ST-segment depression during (n=1) or just after a seizure (n=8).

The interpretation of the findings, that cardiac abnormalities during or after seizures potentially explain SUDEP, raises several questions:

1) ST-segment depression during Holter-monitoring with the used criterion (≥0.10 mV) is a rather unspecific finding, occurring in 11% of healthy men[2]. No details about the recording of Holter-monitoring and the number of leads are given, parameters which influence the rate of false positive findings[3].

2) How many of the patients had cardiovascular symptoms or risk factors like arterial hypertension, diabetes or smoking? Did any of the patients take cardiovascular drugs?

3) Did the ST-segment depression occur repeatedly at each of the seizures or only once? Did ST-segment depression in these patients also occur without seizures? Were the ST-segment depressions associated with any cardiac symptoms or were they silent? Were there any patients without ST- segment depression who had a similar high heart rate like patients who developed ST-segment depression?

4) Were any other abnormalities detected during Holter-monitoring except for ST-segment depression, tachycardia and the complete heart block?

5) Since seizures associated with ST-segment depression occurred during sleep in 7/9 patients, did the authors consider decreased blood oxygen saturation as a potential mechanism for the abnormalities? Was oxygen saturation monitored? Did the authors consider other causes for ST-segment depression like changes in body posture[3]?

6) Was the heart rate during maximal exercise higher or lower than during the epileptic seizures? Was there an association between ST-segment depression at stress test or ischemic changes at scintigraphy and postictal ST-segment depression?

7)Which were the abnormal tests prompting coronary angiography in nine patients? Were these nine patients identical to the nine patients who developed ST-segment depression? Did they suffer from angina pectoris? Were tests for coronary vasospasms carried out?

In view of the limited knowledge about incidence and pathogenesis of SUDEP, there is a need to evaluate all available data. Even if findings suggest some evidence for an arrhythmogenic cause of SUDEP, other causes like cerebral, respiratory or genetic factors should be considered.

References

1. Tigaran S, Molgaard H, McClelland R, Dam M, Jaffe AS. Evidence of cardiac ischemia during seizures in drug refractory epilepsy patients. Neurology 2003;60:492-495.

2. Vaage-Nilsen M, Rasmussen V, Sorum C, Jensen G. ST-segment deviation during 24-hour ambulatory electrocardiographic monitoring and exercise stress test in healthy male subjects 51 to 75 years of age. The Copenhagen City Heart Study. Am Heart J 1999;137:1070-1074.

3. Tzivoni D, Butnaru A. Diagnostic accuracy of ST changes detected by exercise testing and ambulatory electrocardiographic monitoring in apparently healthy individuals. Am Heart J 1999;137:996-999.

20 August 2003
Reply to Stollberger and Finsterer
Simona Tigaran, Aarhus University Hospital
Allan S. Jaffe

The answers to most of the questions raised by Dr. Stollberger and Finsterer are available by a close reading of the manuscript or our paper in Acta Neurologica Scandinavica Supplement : 2002; 177: 9-32, where methods that could not be included due to the word constraints imposed by the journal can be found.

However, the comments question the veracity of the observations. We do not. We studied asymptomatic patients without a history of heart disease or medications for hypertension or cardiac conditions. These patients had a normal physical examination, normal EKGs at rest and negative stress tests to heart rates equivalent to or greater than those that occurred pre- and post- ictally. In cases considered equivocal, patients underwent coronary angiography. No significant coronary artery disease was found. Furthermore, the observed ST-segment changes met rigorous criteria in both Holter leads, during the ictal or post- ictal state, were not seen at other times and can be explained by reasonable pathophysiology. None of the patients complained of symptoms. No patient had more than one episode.

Nonetheless, we agree that additional confirmation is needed for the observations and additional data would be helpful to explain potential mechanisms. We are pursuing such studies.

Information & Authors

Information

Published In

Neurology®
Volume 60Number 3February 11, 2003
Pages: 492-495
PubMed: 12578934

Publication History

Received: November 20, 2001
Accepted: September 1, 2002
Published online: February 11, 2003
Published in print: February 11, 2003

Permissions

Request permissions for this article.

Authors

Affiliations & Disclosures

S. Tigaran, MD PhD
From the Departments of Neurology (Drs. Tigaran and Dam) and Cardiology, Skejby Sygehus (Dr. Mølgaard), Aarhus University Hospital, Aarhus, Denmark; and the Department of Biostatistics (Dr. McClelland) and Division of Cardiovascular Diseases and Laboratory Medicine and Pathology (Dr. Jaffe), Mayo Clinic, Rochester, MN.
H. Mølgaard, DMSc
From the Departments of Neurology (Drs. Tigaran and Dam) and Cardiology, Skejby Sygehus (Dr. Mølgaard), Aarhus University Hospital, Aarhus, Denmark; and the Department of Biostatistics (Dr. McClelland) and Division of Cardiovascular Diseases and Laboratory Medicine and Pathology (Dr. Jaffe), Mayo Clinic, Rochester, MN.
R. McClelland, PhD
From the Departments of Neurology (Drs. Tigaran and Dam) and Cardiology, Skejby Sygehus (Dr. Mølgaard), Aarhus University Hospital, Aarhus, Denmark; and the Department of Biostatistics (Dr. McClelland) and Division of Cardiovascular Diseases and Laboratory Medicine and Pathology (Dr. Jaffe), Mayo Clinic, Rochester, MN.
M. Dam, DMSc
From the Departments of Neurology (Drs. Tigaran and Dam) and Cardiology, Skejby Sygehus (Dr. Mølgaard), Aarhus University Hospital, Aarhus, Denmark; and the Department of Biostatistics (Dr. McClelland) and Division of Cardiovascular Diseases and Laboratory Medicine and Pathology (Dr. Jaffe), Mayo Clinic, Rochester, MN.
A.S. Jaffe, MD
From the Departments of Neurology (Drs. Tigaran and Dam) and Cardiology, Skejby Sygehus (Dr. Mølgaard), Aarhus University Hospital, Aarhus, Denmark; and the Department of Biostatistics (Dr. McClelland) and Division of Cardiovascular Diseases and Laboratory Medicine and Pathology (Dr. Jaffe), Mayo Clinic, Rochester, MN.

Notes

Address correspondence and reprint requests to Dr. Simona Tigaran, Department of Neurology, Aarhus University Hospital, Norrebrogade 44, 8000 Aarhus C, Denmark; e-mail: [email protected]

Metrics & Citations

Metrics

Citations

Download Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.

Cited By
  1. Enlightening the Mechanism of Ferroptosis in Epileptic Heart, Current Medicinal Chemistry, 31, 8, (952-969), (2024).https://doi.org/10.2174/0929867330666230223103524
    Crossref
  2. The Epileptic Heart Syndrome: Epidemiology, pathophysiology and clinical detection, Epilepsy & Behavior Reports, 27, (100696), (2024).https://doi.org/10.1016/j.ebr.2024.100696
    Crossref
  3. Leveraging the Capabilities of AI: Novice Neurology-Trained Operators Performing Cardiac POCUS in Patients with Acute Brain Injury, Neurocritical Care, 41, 2, (523-532), (2024).https://doi.org/10.1007/s12028-024-01953-z
    Crossref
  4. The role of the adenosine system in epilepsy and its comorbidities, British Journal of Pharmacology, 181, 14, (2143-2157), (2023).https://doi.org/10.1111/bph.16094
    Crossref
  5. Seizures Induce Hypoxia, and Hypoxia Induces Seizures: A Perverse Relationship That Increases the Risk of Sudden Unexpected Death in Epilepsy (SUDEP), Pharmacoresistance in Epilepsy, (207-237), (2023).https://doi.org/10.1007/978-3-031-36526-3_11
    Crossref
  6. Sudden unexpected death in epilepsy: A critical view of the literature, Epilepsia Open, 8, 3, (728-757), (2023).https://doi.org/10.1002/epi4.12722
    Crossref
  7. Cardiac structural and functional abnormalities in epilepsy: A systematic review and meta‐analysis, Epilepsia Open, 8, 1, (46-59), (2023).https://doi.org/10.1002/epi4.12692
    Crossref
  8. SUDEP in adults and children, IP Indian Journal of Neurosciences, 7, 4, (259-265), (2022).https://doi.org/10.18231/j.ijn.2021.048
    Crossref
  9. The Epileptic Heart and the Case for Routine Use of the Electrocardiogram in Patients with Chronic Epilepsy, Neurologic Clinics, 40, 4, (699-716), (2022).https://doi.org/10.1016/j.ncl.2022.03.003
    Crossref
  10. Ictal and Interictal Cardiac Manifestations in Epilepsy. A Review of Their Relation With an Altered Central Control of Autonomic Functions and With the Risk of SUDEP, Frontiers in Neurology, 12, (2021).https://doi.org/10.3389/fneur.2021.642645
    Crossref
  11. See more
Loading...

View Options

Login options

Check if you have access through your login credentials or your institution to get full access on this article.

Personal login Institutional Login
Purchase Options

The neurology.org payment platform is currently offline. Our technical team is working as quickly as possible to restore service.

If you need immediate support or to place an order, please call or email customer service:

  • 1-800-638-3030 for U.S. customers - 8:30 - 7 pm ET (M-F)
  • 1-301-223-2300 for customers outside the U.S. - 8:30 - 7 pm ET (M-F)
  • [email protected]

We appreciate your patience during this time and apologize for any inconvenience.

View options

PDF and All Supplements

Download PDF and Supplementary Material

Full Text

View Full Text

Full Text HTML

View Full Text HTML

Media

Figures

Other

Tables

Share

Share

Share article link

Share